A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer
NCT05656092 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 199
Last updated 2025-02-19
Summary
A multicenter, randomized, double-blind, active-controlled, phase III study to evaluate the efficacy and safety of HIP0612 in patients with gastric ulcer.
Conditions
- Gastric Ulcer
Interventions
- DRUG
-
HIP0612
Test drug
- DRUG
-
HPP2202
Placebo drug
- DRUG
-
RLD2204
Reference drug
- DRUG
-
HPP2201
Placebo drug
Sponsors & Collaborators
-
Hanmi Pharmaceutical Company Limited
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-06
- Primary Completion
- 2024-12-19
- Completion
- 2024-12-19
Countries
- South Korea
Study Locations
More Related Trials
-
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment
NCT02084420 ·Status: COMPLETED ·Phase: PHASE3
-
PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
NCT01180179 ·Status: COMPLETED ·Phase: PHASE4
-
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
NCT00125736 ·Status: COMPLETED ·Phase: PHASE4
-
The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
NCT06902818 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic Hemostasis
NCT05005910 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
NCT03050307 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of AD-203
NCT04066530 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
NCT05448001 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control
NCT00713947 ·Status: WITHDRAWN ·Phase: PHASE4
-
Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
NCT02456012 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
NCT06284876 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
NCT04503629 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.
NCT02638584 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare PK, PD and Safety of the AD-214 and AD-2141
NCT05062876 ·Status: COMPLETED ·Phase: PHASE1
-
High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
NCT00709046 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer Bleeding
NCT02108756 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
NCT02724150 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers
NCT05959486 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
NCT00573924 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
NCT04215653 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers
NCT00838682 ·Status: TERMINATED ·Phase: PHASE4
-
Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations
NCT03372850 ·Status: UNKNOWN ·Phase: PHASE1
-
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
NCT00037570 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer
NCT02761512 ·Status: COMPLETED ·Phase: PHASE3